- PACB -4.64%
Search results
- 1.8500Add to watchlist-0.0900 (-4.64%)As of Fri. May 31, 2024 2:01 PM EDT · Nasdaq Real Time Price (USD) · Market open
- Open1.9500High2.0200Low1.8400
- Mkt Cap503.86MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close1.940052 Wk. Low1.250052 Wk. High14.5500
Top storiesPacific Biosciences of California, Inc. (PACB) Is a Trending Stock: Facts to Know Before Betting on ItYahoo Finance · 1 week ago- PACB -4.64%
Pacific Biosciences of California Inc (PACB) Q1 2024 Earnings: Narrowing Losses but Misses ...Yahoo Finance · 3 weeks ago- PACB -4.64%
Pacific Biosciences of California First Quarter 2024 Earnings: Misses ExpectationsYahoo Finance · 3 weeks agoRelated stocks
9/21 12:03 PM. Previous Close 1.8700. Open 1.8800. Bid 1.8600 x 5000. Ask 1.8900 x 7800. Day's Range 1.8100 - 1.9500. 52 Week Range 1.2500 - 14.5500. Volume 5,802,533. Avg. Volume 11,108,478....
Get the latest Pacific Biosciences of California Inc (PACB) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and...
3 days ago · Pacific Biosciences of California Inc. (PACB) is a biotech company that develops and sells sequencing systems and assays. Get the latest stock quote, chart, news, financials, analyst ratings and more on MarketWatch.
May 17, 2024 · Get the latest stock price, news, and insights for PACB, a biotechnology company that develops and commercializes long-read sequencing platforms. See bid, ask, and historical data powered by Nasdaq Data Link.
A high-level overview of Pacific Biosciences of California, Inc. (PACB) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
People also ask
Does PACB pay a dividend?
Does Pacific Biosciences of California (PACB) pay a dividend?
Will PACB stock rise over the next month?
Should you buy PACB stock?
May 24, 2024 · PACB is a biotechnology company that develops sequencing solutions for genomic research. It has a low price/sales ratio, a negative return on equity, and a 42% discount to fair value as of Apr 23, 2024.
Per-Share Earnings, Actuals and Estimates. View the latest Pacific Biosciences of California Inc. (PACB) stock price, news, historical charts, analyst ratings and financial information from WSJ.